Coxiella Burnetii
Download the word version here
Morphology | Gram negative proteobacteria, pleomorphic, spore forming and is an obligate intracellular pathogen. |
---|---|
Disease
|
C. burnetii is the causative agent of Q. fever. Infection begins in the lung alveoli. It does not normally cause disease in its animal hosts, but can cause miscarriage in livestock. |
Zoonosis
|
Yes. |
Host Range | Humans and many different wild and domestic animals. |
---|---|
Modes of Transmission
|
Occurs mainly via inhalation of contaminated aerosols from amniotic fluid, placenta,
or contaminated wool from farm animals, through direct or indirect contact with infected
animals and their dried excreta, contaminated hides, straw, fertilizer, and laundry
of exposed persons.
|
Signs and Symptoms |
Acute Q fever: Presentation varies considerably; typically self-limited flu-like illness, atypical pneumonia, and hepatitis. Chronic Q fever: endocarditis, characterized by fever, hepatitis, weight loss, stroke, or heart failure. |
Infectious Dose | Approximately 1-10 organisms. |
Incubation Period | 13-28 days if acquired through respiratory route. 24-48 hours in people who have accidently inoculated themselves. |
Prophylaxis |
None.
|
---|---|
Vaccines |
Q-vax vaccine is used in Australia.
|
Treatment | Doxycycline, hydroxychloroquine. |
Surveillance |
Presence of clinical symptoms; direct detection of antigen; serological tests.
|
MSU Requirements
|
Report any exposures.
|
Laboratory Acquired Infections (LAIs) | Accounted for the highest number of rickettsia laboratory infections. 278 cases were
reported up to 1976 with 1 death.
|
---|---|
Sources |
Infected arthropods, blood, urine, feces, milk, yolk sac suspensions, contaminated
laundry and clothing, naturally or experimentally infected animals, and tissues of
humans or other hosts.
|
BMBL
|
https://www.cdc.gov/labs/bmbl/?CDC_AAref_Val=https://www.cdc.gov/labs/BMBL.html |
---|---|
NIH Guidelines
|
|
CDC
|
http://www.cdc.gov/qfever/ |
Canada PSDS
|
http://www.phac-aspc.gc.ca/lab-bio/res/psds-ftss/index-eng.php |
Risk Group 2
|
Agents that are associated with human disease which is rarely serious and for which preventive or therapeutic interventions are often available. |
---|---|
BSL2
|
For all procedures involving suspected or known infectious specimen or cultures.
|
ABSL2
|
For all procedures utilizing infected animals infected with Coxiella burnetii.
|
Small
|
Notify others working in the lab. Remove PPE and don new PPE. Cover area of the spill
with absorbent material and add fresh 1:10 bleach:water. Allow 20 munutes (or as directed)
of contact time. After 20 minutes, cleanup and dispose of materials.
|
---|---|
Large
|
|
Mucous membrane
|
Flush eyes, mouth, or nose for 5 minutes at eyewash station.
|
---|---|
Other Exposures
|
Wash area with soap and water for 5 minutes.
|
Reporting |
Immediately report incident to supervisor, complete a First Report of Injury form, and submit to Safety and Risk Management.
|
Medical Follow-up
|
During business hours: Bridger Occupational Health 3406 Laramie Drive. Weekdays 8am -6pm. Weekends 9am-5pm
After business hours: Bozeman Deaconess Hospital Emergency Room 915 Highland Blvd Bozeman, MT |
Disinfection |
Susceptible to 5 % Micro-Chem, 70 % ethanol, and 10 % formalin.
|
---|---|
Inactivation |
Inactivated by moist heat (15 minutes at 121oC) and dry heat (1 hour at 160-170oC).
|
Survival Outside Host
|
Survives in soil, contaminated buildings, food and fomites for years.
|
Minimum PPE Requirements
|
Lab coat, disposable gloves, safety glasses, closed toed shoes, long pants
|
---|---|
Additional Precautions
|
Additioanl PPE may be required depending on lab specific SOPs and IBC Protocol. |